NISCI - Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial (NISCI)
- Project Identification
- 681094
- Project Period
- 1/2016 - 6/2023
- Investor / Pogramme / Project type
-
European Union
- Horizon 2020
- Health, demographic change and wellbeing (Societal Challenges)
- MU Faculty or unit
- Faculty of Medicine
- Cooperating Organization
-
University Hospital Prague - Motol
Ruhr-Universität Bochum
Universität Zürich
- Responsible person Sofia Karakostas
Heidelberg University Hospital
Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial.
Publications
Total number of publications: 2
2021
-
Generic acquisition protocol for quantitative MRI of the spinal cord
Nature Protocols, year: 2021, volume: 16, edition: 10, DOI
-
Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers
Scientific Data, year: 2021, volume: 8, edition: 1, DOI